Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Microbiology

Contamination Control in Cell Culture: Detection and Prevention of Mycoplasma

Detailed view of a microscope in a laboratory used in scientific research
Photo by indra projects on Pexels.

Mycoplasma contamination is one of the most pervasive and insidious problems in cell culture laboratories, affecting an estimated 5–30% of continuous cell lines worldwide. These cell wall‑less bacteria evade routine light microscopy, resist common antibiotics, and alter virtually every cellular parameter—from metabolism and gene expression to virus susceptibility and protein production. The definitive approach to mycoplasma control combines routine detection using PCR‑based methods (the current gold standard for sensitivity and speed) with strict preventive measures, including antibiotic‑free culture, aseptic technique, and regular quarantine of incoming cell lines. This article provides a practical, evidence‑based framework for establishing a mycoplasma contamination control program suitable for BSL‑1 teaching and research laboratories.

At a Glance

Aspect Key Information
Primary detection method PCR (conventional or qPCR) targeting conserved 16S rRNA gene sequences
Alternative detection methods Direct DNA staining (Hoechst 33258, DAPI), culture on agar, ELISA, biochemical assays
Sample type Cell culture supernatant, cell lysate, or conditioned medium
Detection limit (PCR) Typically 10–100 genome copies per reaction
Turnaround time (PCR) 2–4 hours
Turnaround time (culture) 7–28 days
Prevention cornerstone Antibiotic‑free culture with routine testing
Biosafety level BSL‑1 for routine testing of established cell lines
Key controls Positive control (known mycoplasma DNA), negative control (sterile water), internal amplification control

Scientific Principle: Why Mycoplasma Are Difficult to Detect and Eliminate

Mycoplasma species (class Mollicutes) are the smallest self‑replicating organisms, typically 0.2–0.3 µm in diameter—small enough to pass through standard 0.45 µm filters used in media preparation. They lack a cell wall, rendering them insensitive to β‑lactam antibiotics (penicillins, cephalosporins) and making them morphologically invisible under bright‑field microscopy. In cell culture, mycoplasma compete for nutrients, produce toxic metabolites (e.g., ammonia, hydrogen peroxide), and can induce chromosomal aberrations, altered growth rates, and changes in surface antigen expression. These effects can silently compromise experimental results for weeks or months before overt signs (e.g., media acidification, reduced viability) appear.

The 16S ribosomal RNA gene is the primary molecular target for detection because it contains both highly conserved regions (allowing broad‑spectrum detection across >100 mycoplasma species) and variable regions (enabling species identification). PCR‑based methods exploit this conserved sequence to amplify mycoplasma DNA from cell culture samples, providing sensitivity far exceeding that of culture‑based methods. As demonstrated in clinical contexts, species‑specific qPCR can detect as few as 10–100 copies of target DNA per reaction, enabling early intervention before contamination spreads [4].

Materials and Instrumentation Choices

PCR‑Based Detection

Essential materials:

  • DNA extraction kit (column‑based or magnetic bead‑based) suitable for cell culture supernatant or cell lysate
  • PCR master mix (conventional or real‑time) containing DNA polymerase, dNTPs, buffer, and Mg²⁺
  • Mycoplasma‑specific primer set targeting the 16S rRNA gene (e.g., primers GPO‑1 and MGSO, or commercial primer mixes)
  • Positive control: purified mycoplasma DNA (e.g., M. arginini or M. hyorhinis genomic DNA) or a plasmid containing the target amplicon
  • Negative control: nuclease‑free water
  • Internal amplification control (optional but recommended): a synthetic DNA template with a distinct primer set to detect PCR inhibition
  • Real‑time PCR instrument (for qPCR) or thermal cycler with gel electrophoresis equipment (for conventional PCR)

Critical decision points:

  • Primer selection: Broad‑range primers targeting conserved 16S rRNA regions can detect most mycoplasma species but may also amplify some closely related bacteria. Species‑specific primers (e.g., for M. pneumoniae or M. hominis) are used when a particular contaminant is suspected [3]. For routine screening, a broad‑range primer set is preferred.
  • PCR chemistry: SYBR Green‑based qPCR is cost‑effective but requires melt curve analysis to confirm specificity. Probe‑based qPCR (e.g., TaqMan) provides higher specificity and allows multiplexing with an internal control.
  • DNA extraction method: Column‑based kits yield high‑purity DNA but may lose small DNA fragments. Magnetic bead methods are gentler and can recover low‑molecular‑weight DNA, which is advantageous for mycoplasma detection.

Alternative Detection Methods

Direct DNA staining (Hoechst 33258 or DAPI):

  • Fluorescent DNA stain that binds to A‑T rich regions
  • Requires a fluorescence microscope with appropriate filter set (350 nm excitation, 460 nm emission for Hoechst)
  • Detects extranuclear DNA in the cytoplasm or on cell surfaces
  • Limitations: Lower sensitivity than PCR (requires >10⁴ mycoplasma per mL); cannot distinguish mycoplasma from other DNA‑containing contaminants; requires experience to differentiate from background fluorescence

Mycoplasma culture on agar:

  • Specialized mycoplasma agar (e.g., Hayflick’s medium, SP‑4 medium) incubated at 37°C in 5% CO₂ for 7–28 days
  • Characteristic “fried‑egg” colonies (10–100 µm diameter) visible under a dissecting microscope
  • Limitations: Extremely slow; many mycoplasma species are fastidious and may not grow; requires species‑specific media supplements; turnaround time is impractical for routine monitoring

Biochemical assays (e.g., mycoplasma detection kits based on enzyme activity):

  • Detect mycoplasma‑specific enzymes (e.g., arginine deiminase, urease)
  • Rapid (30–60 minutes) but less sensitive than PCR
  • Useful as a preliminary screen but not definitive

Controls: The Backbone of Reliable Detection

Every mycoplasma detection assay must include appropriate controls to validate results. The following controls are essential for PCR‑based methods:

Control Composition Purpose
Positive control Purified mycoplasma DNA (10³–10⁴ copies) Confirms the PCR reaction is working; verifies primer specificity
Negative control (no‑template) Nuclease‑free water Detects reagent contamination with mycoplasma DNA
Extraction control Sterile culture medium processed through the entire DNA extraction Detects contamination introduced during extraction
Internal amplification control (IAC) Synthetic DNA with distinct primer binding sites Detects PCR inhibition (e.g., from media components)
Cell line control Known mycoplasma‑free cell line (e.g., Vero or HEK293 certified free) Validates the entire workflow from sample collection to result

Why each control matters:

  • A positive control that fails to amplify indicates a problem with the PCR master mix, thermal cycler, or primer design.
  • A negative control that amplifies indicates contamination of reagents or workspace—all results from that run are invalid.
  • An IAC that fails to amplify in a sample that also shows no mycoplasma signal suggests PCR inhibition, requiring sample dilution or re‑extraction.
  • A cell line control that tests positive indicates either the control line is contaminated (requiring replacement) or the detection system has a specificity issue.

Conceptual Workflow for Routine Mycoplasma Testing

Step 1: Sample Collection

Collect 1–2 mL of cell culture supernatant from a culture that has been growing for at least 48 hours without medium change. For adherent cells, collect supernatant after the cells have reached 70–90% confluence. For suspension cells, collect supernatant after the culture has reached a density of at least 5 × 10⁵ cells/mL. If testing a newly received cell line, collect samples from the first passage after thawing.

Edge case: If the culture medium contains antibiotics (e.g., penicillin‑streptomycin), mycoplasma may be suppressed but not eliminated. Collect samples from cultures that have been passaged at least twice in antibiotic‑free medium to allow any suppressed mycoplasma to proliferate to detectable levels.

Step 2: DNA Extraction

Extract DNA from 200 µL of supernatant using a column‑based kit according to the manufacturer’s instructions. Elute in 50–100 µL of elution buffer. For cell lysates (if using cells directly), wash cells twice with PBS to remove serum components that may inhibit PCR, then lyse with proteinase K and extraction buffer.

Quality check: Measure DNA concentration and purity (A₂₆₀/A₂₈₀ ratio of 1.8–2.0). However, mycoplasma DNA may be present at concentrations below the detection limit of spectrophotometry; do not rely on concentration measurements alone to confirm successful extraction.

Step 3: PCR Setup

Prepare the PCR master mix in a dedicated clean area (e.g., PCR hood with UV sterilization). Include:

  • 12.5 µL of 2× master mix
  • 0.5 µL each of forward and reverse primers (10 µM)
  • 0.5 µL of IAC template (if using)
  • 9.5 µL of nuclease‑free water
  • 2 µL of template DNA

Total reaction volume: 25 µL. Include positive, negative, and extraction controls in every run.

Step 4: Thermal Cycling

For conventional PCR:

  • Initial denaturation: 95°C for 5 minutes
  • 35–40 cycles: 95°C for 30 seconds, 55–60°C for 30 seconds, 72°C for 30 seconds
  • Final extension: 72°C for 5 minutes

For qPCR:

  • Same cycling parameters but with fluorescence acquisition at the end of each annealing/extension step
  • Include a melt curve step (e.g., 65–95°C with 0.5°C increments) for SYBR Green assays

Note: Annealing temperature depends on primer melting temperature (Tₘ). Optimize using a temperature gradient (e.g., 50–65°C) if using a new primer set.

Step 5: Analysis

Conventional PCR: Run products on a 2% agarose gel with a 100 bp DNA ladder. A band at the expected size (typically 250–500 bp for mycoplasma 16S rRNA primers) indicates a positive result.

qPCR: A Cq value < 35 with a single melt peak at the expected Tₘ indicates a positive result. Cq values between 35 and 40 are equivocal and require repeat testing or confirmation by an alternative method.

Quality Checks and Result Interpretation

Valid Run Criteria

A PCR run is valid only if:

  1. The positive control shows amplification (Cq < 30 for qPCR, visible band for conventional PCR)
  2. The negative control shows no amplification (Cq > 40 or no band)
  3. The extraction control shows no amplification
  4. The IAC amplifies in all samples (Cq within expected range)

Interpreting Results

Result Pattern Interpretation Action
Positive control +, negative control –, sample + Mycoplasma detected Confirm with alternative method; quarantine culture
Positive control +, negative control –, sample – Mycoplasma not detected Continue routine testing; no action needed
Positive control –, any sample result PCR failure Repeat run with fresh reagents
Negative control + Reagent contamination Discard all reagents; decontaminate workspace
IAC fails in sample, sample negative PCR inhibition Dilute sample 1:10 and repeat; or re‑extract DNA

False Positives and False Negatives

False positives can arise from:

  • Carryover contamination from previous PCR products (amplicon contamination)
  • Contaminated reagents or plasticware
  • Cross‑contamination during sample handling

Mitigation: Use separate areas for pre‑PCR (clean) and post‑PCR (dirty) work. Use aerosol‑barrier pipette tips. Include multiple negative controls.

False negatives can arise from:

  • PCR inhibition by media components (e.g., heparin, phenol red, serum)
  • Low mycoplasma burden (below detection limit)
  • Primer mismatch with unusual mycoplasma species
  • DNA degradation during storage

Mitigation: Include IAC to detect inhibition. Test samples from cultures at high density. Store extracted DNA at –20°C and avoid freeze‑thaw cycles.

Troubleshooting Table

Observation Likely Cause Discriminating Check
Positive control fails to amplify Degraded primers or master mix; thermal cycler malfunction Test with a different primer set or master mix; run a control PCR with a different target
Negative control shows amplification Reagent contamination; amplicon carryover Replace all reagents; UV‑treat PCR hood; use fresh aliquots
Sample shows weak band or high Cq Low mycoplasma burden; partial PCR inhibition Repeat with undiluted and 1:10 diluted DNA; test a different sample from the same culture
Melt curve shows multiple peaks (SYBR Green) Non‑specific amplification; primer‑dimer Reduce primer concentration; increase annealing temperature; redesign primers
IAC fails in all samples Master mix problem; IAC template degraded Prepare fresh master mix; use new IAC aliquot
IAC fails in one sample only PCR inhibition in that sample Dilute sample 1:5 and 1:10; re‑extract with additional wash steps
Culture‑based detection positive, PCR negative Unusual mycoplasma species not targeted by primers; PCR inhibition Use broad‑range primers; sequence the cultured isolate to identify species
PCR positive, culture negative Non‑viable mycoplasma; PCR contamination; non‑mycoplasma target Repeat PCR with species‑specific primers; sequence the amplicon; test a fresh sample

Limitations of Mycoplasma Detection Methods

PCR Limitations

  • Primer bias: Broad‑range primers may miss some mycoplasma species (e.g., M. penetrans, M. pirum) if sequence mismatches occur in the primer binding regions.
  • Inability to distinguish viable from non‑viable organisms: PCR detects DNA from dead mycoplasma, which may persist after antibiotic treatment or disinfection.
  • Inhibition: Cell culture media components (especially heparin, EDTA, and high concentrations of serum) can inhibit PCR. Always include an IAC.
  • Amplicon contamination risk: PCR products from positive samples can contaminate future reactions if strict spatial separation is not maintained.

Culture Limitations

  • Slow growth: Most mycoplasma species require 7–14 days for visible colony formation; some require up to 28 days.
  • Fastidious species: Many mycoplasma species (e.g., M. hyorhinis, M. fermentans) are difficult to culture on artificial media and may require specialized supplements (e.g., fresh yeast extract, horse serum).
  • Overgrowth by bacteria: If the sample contains bacteria, they will outgrow mycoplasma on non‑selective media. Use selective media with antibiotics (e.g., thallium acetate, penicillin) to suppress bacterial growth.
  • Low sensitivity: Culture can detect as few as 10–100 colony‑forming units (CFU) per mL, but many contaminated cultures have lower burdens.

Staining Limitations

  • Low sensitivity: Requires >10⁴ organisms per mL for reliable detection.
  • Non‑specificity: Fluorescent dyes stain all DNA, including mitochondrial DNA and debris from dead cells.
  • Subjectivity: Interpretation requires experience; inexperienced observers may mistake background fluorescence for mycoplasma.

Documentation and Record Keeping

A robust mycoplasma control program requires meticulous documentation. For each testing event, record:

  1. Sample information: Cell line name, passage number, date of last medium change, antibiotic status
  2. Sample collection details: Volume collected, collection date, storage conditions
  3. DNA extraction: Kit used, elution volume, DNA concentration (if measurable)
  4. PCR setup: Primer set, master mix lot number, thermal cycler used, cycling parameters
  5. Controls: Positive control identity and concentration, negative control results, IAC results
  6. Results: Gel image or amplification plot, Cq values (qPCR), band sizes (conventional PCR)
  7. Interpretation: Positive/negative/equivocal, any repeat testing performed
  8. Action taken: Quarantine, discard, treatment, or release of cell line

Store all raw data (gel images, amplification plots) in a secure laboratory information management system (LIMS) or a structured folder system with date‑stamped files. Maintain a master log of all cell lines in the laboratory, their mycoplasma status, and the date of last testing.

Biosafety Considerations

Mycoplasma detection in cell culture is a BSL‑1 procedure when working with established cell lines that are not known to harbor human pathogens. However, follow these safety practices:

  • Work in a Class II biological safety cabinet (BSC) when handling live cell cultures and during sample collection to prevent aerosol exposure.
  • Treat all cell culture waste as potentially contaminated. Decontaminate spent media and culture vessels with 10% bleach (0.5% sodium hypochlorite) for at least 30 minutes before disposal.
  • Use personal protective equipment (PPE): Lab coat, gloves, and eye protection. Change gloves after handling potentially contaminated samples.
  • Decontaminate work surfaces with 70% ethanol or a commercial disinfectant effective against mycoplasma (e.g., 0.1% SDS, 1% Virkon). Note that 70% ethanol is not sporicidal but is effective against mycoplasma due to their lack of a cell wall.
  • Never use antibiotics to mask contamination. Antibiotic‑free culture is essential for early detection. If antibiotics are used for other purposes (e.g., selection of transfected cells), maintain parallel antibiotic‑free cultures for mycoplasma testing.
  • Follow institutional biosafety committee (IBC) guidelines for work with recombinant DNA if using PCR primers or plasmids as positive controls [7]. The NIH Guidelines require IBC approval for experiments involving recombinant or synthetic nucleic acids [7].

Preventive Measures: Building a Contamination‑Free Culture System

1. Quarantine and Test Incoming Cell Lines

All new cell lines (from other laboratories, commercial sources, or tissue banks) must be quarantined in a separate incubator or a dedicated area of the laboratory until mycoplasma testing is completed. Test at least two independent samples (e.g., from the first and second passages) before releasing the line for general use.

2. Maintain Antibiotic‑Free Cultures

Continuous use of antibiotics (penicillin‑streptomycin, gentamicin) selects for resistant mycoplasma and suppresses low‑level contamination, making detection difficult. Maintain all routine cultures in antibiotic‑free medium. If antibiotics are required for selection (e.g., puromycin for transfected cells), maintain a parallel antibiotic‑free culture for testing.

3. Practice Strict Aseptic Technique

  • Use sterile, disposable pipettes and serological pipettes for each culture.
  • Never pour media directly from bottles; use sterile pipettes or disposable sterile filters.
  • Wipe all surfaces (BSC, incubator handles, microscope stage) with 70% ethanol before and after use.
  • Change gloves between handling different cell lines.
  • Use separate media bottles for each cell line to prevent cross‑contamination.

4. Routine Testing Schedule

  • All active cell lines: Test every 2–4 weeks.
  • Newly received lines: Test at first passage and again after 2 weeks in culture.
  • After any contamination event: Test all lines that were in the same incubator or BSC.
  • Before cryopreservation: Test a sample from the culture to be frozen.
  • After thawing: Test the first passage after recovery.

5. Environmental Monitoring

Periodically test incubator water pans, BSC surfaces, and media bottles for mycoplasma contamination. Use swabs moistened with sterile PBS to sample surfaces, then test by PCR.

6. Staff Training

All laboratory personnel must receive training on:

  • Recognizing signs of mycoplasma contamination (e.g., altered growth, media pH changes)
  • Proper aseptic technique
  • Sample collection for mycoplasma testing
  • Interpretation of test results
  • Response protocol for confirmed contamination

Frequently Asked Questions

Q1: How often should I test my cell lines for mycoplasma? For actively used cell lines, test every 2–4 weeks. Test more frequently (weekly) if you are working with multiple lines in the same incubator or if you have recently experienced a contamination event. Always test before cryopreserving cells and after thawing a new vial.

Q2: Can I use antibiotics to eliminate mycoplasma from a contaminated culture? Antibiotic treatment (e.g., with BM‑Cyclin, mycoplasma removal agent, or ciprofloxacin) can suppress but rarely eliminates mycoplasma completely. Treated cultures often harbor low levels of resistant organisms that can re‑emerge. The recommended approach is to discard contaminated cultures and obtain a clean replacement. If the culture is irreplaceable, treat with validated antibiotics, then test repeatedly (at least three negative tests over 4 weeks) before considering the culture clean.

Q3: My PCR test shows a positive result, but the culture looks healthy. Is this a false positive? A positive PCR result should always be taken seriously, even if the culture appears healthy. Mycoplasma contamination can exist at low levels for weeks without visible effects. Confirm the result with an alternative method (e.g., a different primer set, DNA staining, or culture). If confirmed, quarantine the culture and either discard it or treat it. Do not assume a false positive without confirmatory testing.

Q4: Can I use the same PCR primers for all mycoplasma species? Broad‑range primers targeting conserved 16S rRNA sequences can detect most common mycoplasma species (e.g., M. arginini, M. hyorhinis, M. orale, M. fermentans, Acholeplasma laidlawii). However, some species (e.g., M. penetrans, M. pirum) may have sequence mismatches. For comprehensive screening, use a validated commercial primer set that has been tested against a broad panel of mycoplasma species. If you suspect a specific species (e.g., M. pneumoniae in respiratory samples), use species‑specific primers [3].

References and Further Reading

  1. Innovative exploration of Hep-2 cell culture in the isolation and culture of Mycoplasma pneumoniae — Wu W, Zhu W, Tong J, et al. (2025). Demonstrates the use of cell culture for mycoplasma isolation and qPCR detection.
  2. Contamination rates in umbilical cord mesenchymal stromal cell cryopreservation: a report from Vinmec tissue bank — Nguyen TT, Nguyen CQ, Nguyen TD, et al. (2026). Reports microbial contamination monitoring in cell culture workflows.
  3. Performance evaluation and application of a multiplex PCR capillary electrophoresis method for detecting nucleic acids of seven sexually transmitted pathogens — Dai Y, Wang K, Wu Y, et al. (2026). Describes multiplex PCR for detecting mycoplasma and ureaplasma species.
  4. Head trauma complicated with multi-site infections of Ureaplasma urealyticum and Mycoplasma hominis: a case report — Bai X, Sang Y, Ke L, et al. (2025). Illustrates the use of species‑specific qPCR for mycoplasma detection.
  5. Rickettsia felis meningoencephalitis in a child: a case report and literature review — Li X, Jiang Y, Dai R, et al. (2026). Discusses metagenomic sequencing for pathogen detection and contamination control.
  6. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition — CDC and NIH (2020). Authoritative principles for laboratory biosafety and containment.
  7. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules — National Institutes of Health. Institutional framework for recombinant DNA research.
  8. NCBI Bookshelf: Molecular Biology and Laboratory Methods — National Center for Biotechnology Information. Searchable collection of biomedical methods references.

Related Articles